| Bioactivity | Peptide5, a connexin 43 mimetic peptide, reduce animals swelling, astrogliosis, and neuronal cell death after spinal cord injury[1] |
| Invitro | Peptide5, significantly reduces the degree of spinal cord injury (SCI) in a rodent ex vivo model. Peptide5 produces the more significant reduction in swelling and is analyzed further. Treatment with peptide5 reduced both the level of Cx43 and the number of glial fibrillary acidic protein (GFAP)-positive astrocytes, and at the same time reduces the loss of NeuN- and SMI-32–positive neurons in a concentration- and time-dependent manner[1]. |
| Name | Peptide5 |
| CAS | 916977-43-0 |
| Shortening | VDCFLSRPTEKT |
| Formula | C60H98N16O20S |
| Molar Mass | 1395.58 |
| Transport | Room temperature in continental US; may vary elsewhere. |
| Storage | Please store the product under the recommended conditions in the Certificate of Analysis. |
Peptide5
CAS: 916977-43-0 F: C60H98N16O20S W: 1395.58
Peptide5, a connexin 43 mimetic peptide, reduce animals swelling, astrogliosis, and neuronal cell death after spinal cor
Sales Email：peptidedb@qq.com
This product is for research use only, not for human use. We do not sell to patients.